7thInternational Immunoglobulin Conference: Mechanisms of Action
Authors:
- 29 December 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 178 (S1) , 87-88
Abstract
Although intravenous immunoglobulin (IVIg) is widely used for replacement therapy in immunodeficiencies and to treat autoimmune and inflammatory diseases, its mechanisms of action are not fully understood. Examination of immunoglobulin (Ig) receptors, including the Fc-gamma receptors (FCRs) and the neonatal Fc receptor, have revealed genetic variations that are linked to autoimmune diseases and to the efficacy of IVIg treatment. However, the beneficial effect of IVIg encompasses multiple mechanisms of action. One of these is scavenging of activated complement fragments, such as C3a, C5a, C3b and C4b, by infused Ig molecules. This interaction prevents binding of complement fragments to their receptors on target cells, thus attenuating the immune damage. Additionally, anti-inflammatory effects may be facilitated by IgA via specific receptors and/or complement scavenging. Glycosylation of both the Fc- and Fab-fragments has also been implicated in the anti-inflammatory action of IVIg. Although there is evidence to support a role for sialylated IgG glycovariants in mediating the effect of IVIg, evidence from animal models of inflammatory disease suggest that sialylation may not be a critical factor. However, an increase in IgG glycosylation has been observed following IVIg treatment in Guillain-Barre syndrome patients, and this has been associated with improved clinical outcomes.Keywords
Funding Information
- Centre for Innovation
- Canadian Blood Services
- Health Canada
This publication has 8 references indexed in Scilit:
- Therapeutic Effect of IVIG on Inflammatory Arthritis in Mice Is Dependent on the Fc Portion and Independent of Sialylation or BasophilsThe Journal of Immunology, 2014
- IgG Fc N-Glycosylation in Guillain–Barré Syndrome Treated with ImmunoglobulinsJournal of Proteome Research, 2014
- Secretory IgA Induces Tolerogenic Dendritic Cells through SIGNR1 Dampening Autoimmunity in MiceThe Journal of Immunology, 2013
- Sialylation‐independent mechanism involved in the amelioration of murine immune thrombocytopenia using intravenous gammaglobulinTransfusion, 2012
- In vivo enzymatic modulation of IgG glycosylation inhibits autoimmune disease in an IgG subclass-dependent mannerProceedings of the National Academy of Sciences, 2008
- A variable number of tandem repeats polymorphism influences the transcriptional activity of the neonatal Fc receptor α‐chain promoterImmunology, 2006
- Identification of FcαRI as an Inhibitory Receptor that Controls InflammationImmunity, 2005
- Regulation of complement activity by immunoglobulin. I. Effect of immunoglobulin isotype on C4 uptake on antibody-sensitized sheep erythrocytes and solid phase immune complexesThe Journal of Immunology, 1996